...
首页> 外文期刊>Tropical Medicine and International Health: TM and IH >Effect of pregnancy on immunological and virological outcomes of women on ART: A prospective cohort study in rural Uganda, 2004-2009
【24h】

Effect of pregnancy on immunological and virological outcomes of women on ART: A prospective cohort study in rural Uganda, 2004-2009

机译:妊娠对妇女接受抗病毒治疗的免疫和病毒学结果的影响:乌干达农村地区的一项前瞻性队列研究,2004-2009年

获取原文
获取原文并翻译 | 示例

摘要

Objectives Before antiretroviral therapy (ART) introduction, pregnancy was associated with a sustained drop in CD4 cell count in HIV-infected women. We examined the effects of pregnancy on immunological and virological ART outcomes. Methods Between January 2004 and March 2009, we studied HIV-infected women receiving ART in a prospective open cohort study in rural Uganda. We used random effects regression models to compare the CD4 counts of women who became pregnant and those who did not, and among the pregnant women before and after pregnancy. CD4 count and proportions with detectable viral load (≥400copies/ml) were compared between the two groups using the Mann-Whitney rank sum test and logistic regression respectively. Results Of 88 women aged 20-40years receiving ART, 23 became pregnant. At ART initiation, there were no significant differences between those who became pregnant and those who did not in clinical, immunological and virological parameters. Among women who became pregnant, CD4 cell count increased before pregnancy (average 75.9cells/mm 3 per year), declined during pregnancy (average 106.0) but rose again in the first year after delivery (average 88.6). Among women who did not become pregnant, the average CD4 cell count rise per year for the first 3years was 88.5. There was no significant difference in the proportions of women with detectable viral load at last clinic visit among those who became pregnant (8.7%) and those who did not (16.1%), P=0.499. Conclusion Pregnancy had no lasting effect on the immunological and virological outcomes of HIV-infected women on ART.
机译:目的在引入抗逆转录病毒疗法(ART)之前,怀孕与HIV感染妇女的CD4细胞计数持续下降有关。我们检查了妊娠对免疫学和病毒学ART结果的影响。方法2004年1月至2009年3月,我们在乌干达农村进行了一项前瞻性开放队列研究,研究了接受ART感染的HIV感染妇女。我们使用随机效应回归模型比较了怀孕妇女和未怀孕妇女以及怀孕前后孕妇的CD4计数。分别使用Mann-Whitney秩和检验和logistic回归比较两组中CD4计数和可检测病毒载量(≥400拷贝/ ml)的比例。结果88名20至40岁的妇女接受抗逆转录病毒治疗,其中23人怀孕。在开始抗逆转录病毒治疗时,那些怀孕的人与没有临床,免疫和病毒学参数的人之间没有显着差异。在怀孕的妇女中,CD4细胞计数在怀孕前增加(平均每年75.9细胞/ mm 3),在怀孕期间下降(平均106.0),但在分娩后的第一年再次增加(平均88.6)。在未怀孕的妇女中,前三年的平均CD4细胞计数每年增长88.5。在上次诊所就诊时,可检测到病毒载量的妇女比例在那些怀孕的妇女(8.7%)和没有怀孕的妇女(16.1%)之间没有显着差异,P = 0.499。结论妊娠对HIV感染妇女接受抗逆转录病毒疗法的免疫和病毒学结果没有持久影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号